Table 1 PARI LC Nebulizer MADD via Impactor for Nanosuspension on Different Dose Range
From: Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery
Formulation Concentration (mg/mL) | Duration (min) | MMAD (μm) |
|---|---|---|
21.74 | 2.0 | 3.6 |
4.35 | 4.0 | 4.1 |
2.44 | 4.0 | 3.5 |
0.43 | 8.0 | 3.9 |
0.04 | 8.0 | 3.4 |
Average 3.7 ± 0.3 |